Integriculture Inc., a food tech company aiming to reform modern agriculture through “clean meat (cultured meat)” production, has completed a seed round financing led by GLOCALINK Inc. on Dec. 28th 2016.
The seed round financing will allow Integriculture to accelerate the development of low-cost, serum-free culture medium and scalable, flow-based coculture system, both of which are necessary for early market entry.
For details, please refer to the following announcement.
Announcement of Third-Party Allocation of New Shares
-Integriculture Accelerates Cultured Meat Production-
Integriculture Inc. (Headquarters: Tokyo, CEO: Yuki Hanyu, hereinafter referred to as “Integriculture”), a food tech company aiming to reform current agriculture through “clean meat (cultured meat)” production, won the right to investment at the “2nd Agriscience Grand Prix” organized by Leave a Nest Co.,ltd. Integriculture exercised this right on Dec 28th 2016, thereby securing funds through third-party allotment of new shares to GLOCALINK Inc, a subsidiary of Leave a Nest Co.,ltd.
By providing cultured meat at an affordable price range, Integriculture aims to eliminate the environmental burdens and public health risks caused by current meat production.
To realize its vision, Integriculture is developing low-cost culture medium that makes up most of the raw material costs, as well as scalable cell culture system.
It costs several million yen to produce 100 grams of cultured meat with conventional cell culture method. Therefore, Integriculture developed low-cost, serum-free culture medium and scalable, flow-based cell culture system that together produce 100 grams of cultured meat for approximately 40,000 yen.
2. Future Business
The most notable advantage of Integriculture’s low-cost, serum-free culture medium and its patented, scalable cell culture system is their ability to produce large amounts of cultured meat at low cost.
Integriculture has focused on the aforementioned technologies based on its research finding that the greatest challenge for cultured meat production lies in the scalability of cell culture system as well as the cost reduction of culture medium.
Integriculture will leverage the seed round financing to gradually reduce the culture medium cost and scale the culture system. Integriculture aims to prototype cultured foie gras by 2018 and deliver its first cultured meat product by 2021.
By 2025, Integriculture aspires to produce cultured meat at the costs equivalent to conventional meat to ensure food security and provide sustainable meat supplies for the rapidly growing demand across the world.
Integriculture’s Culture Medium
Integriculture greatly reduces the cost of culture medium by replacing the fetal bovine serum (FBS) in the conventional culture medium with “FBS substitutes” found in common food.
By integrating it with its patented culture system, Integriculture reduces the cost of culture medium necessary for cultured meat production down to 10 yen or less per liter, that is, to one ten‐thousandth of the conventional one.
Integriculture’s Cell Culture System
By growing muscle cells and a type of cells that produce growth factors together, Integriculture’s patented cell culture system reduces the aforementioned culture medium cost and thereby enable highly efficient production of cultured meat.
Unlike the conventional disposable batch system, Integriculture’s system grows cells through continuous flow process, meaning that its system can be scaled through parallelization and upsizing.